Industry Insights Logo

A Neutral Clearinghouse: An Area of Potential Collaboration Between Covered Entities, Manufacturers and Payers

SPONSORED CONTENT

Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need to protect themselves from the problem of duplicate discounts.  Federal law affords such protection for drugs dispensed or administered to Medicaid

Read More »
Industry Insights Logo

An Emerging Threat to Your 340B Program: DSH Percentage Reductions

SPONSORED CONTENT

The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands full defending the safety net program from contract pharmacy restrictions, state-level reporting, proposed legislative changes, the IRA, rebate models, and

Read More »
Industry Insights Logo

Is Your 340B Partner a Good Fit? Look for These Signs

SPONSORED CONTENT

Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Stephanie Blaskoski, Regional Manager, SunRx

Stephanie Blaskoski

Q: Where did you grow up?

I grew up in the suburbs of Atlanta.

Q: Where did you go to college?

I received my Bachelor of Science in Biomedical Sciences from Auburn University.

Q: What are your favorites?

Food:  Probably ice cream!

Movie:  Avengers: Endgame

Musicians: I love most music- anything from country to

Read More »
Industry Insights Logo

Mission Multiplied: Unlocking the Full Potential of 340B to Fuel Community Health

SPONSORED CONTENT

When it comes to doing more with less, Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) are unmatched. These mission-driven organizations are lifelines in underserved communities, delivering critical care where it’s needed most. And for many, the 340B program has become

Read More »
Industry Insights Logo

A Coming Storm—or Opportunity: How the 340B Rebate Pilot and Medicare MFP Could Strain or Strengthen the Drug Supply Chain

SPONSORED CONTENT

The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and Services Administration (HRSA) announced a voluntary 340B Rebate Model Pilot, aligned with the Inflation Reduction Act’s Maximum Fair Price (MFP) provisions

Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »
Industry Insights Logo

The Compliance Arms Race: Can Smaller Covered Entities Keep Up?

SPONSORED CONTENT

The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), especially rural hospitals and community clinics, keeping pace feels like a losing race. While large health systems deploy entire

Read More »

Plenful

Q: Tell us some interesting details about your company’s history.

Plenful was founded with a clear mission: to transform healthcare operations from the inside out. Our Founder

Read More »

Expert Tip from Visante

img
img

TIP: When a covered entity participates with 340B ESP™ to obtain 340B pricing restoration, it is critical to monitor manufacturer policies, ESP eligibility,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live